Prevalence, patterns, drivers, and perceived benefits of herbal medicine use in COVID-19 patients in Qatar
Background Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged as a global health crisis in early 2020, leading to widespread morbidity and mortality. In Qatar, as of December 2024, the disease burden has reached over 500,000 cases...
Saved in:
Main Authors: | Raneem Alsheikh, Fatima R. Alsharif, Nouran Alwisi, Zachariah Nazar, Mohamed Ahmed Syed, Hamda Abdulla Qotba, Layla Al-Mansoori, Zumin Shi, Abdullah A. Shaito |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Journal of Pharmaceutical Policy and Practice |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/20523211.2025.2533258 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lobbying of Qatar's Interests in the United States and the Qatar Diplomatic Crisis
by: D. B. Grafov
Published: (2020-04-01) -
Assessment of Small and Medium Enterprises Insolvency to Banks in Qatar
by: N. Shirazi, et al.
Published: (2023-04-01) -
Quantifying the role of mangroves in carbon sequestration in Qatar's mangrove forests
by: Fabiha Sadaf Hussain, et al.
Published: (2025-12-01) -
Seroprevalence of Toxoplasma gondii in goats and sheep in Qatar
by: Asma Mushahidur Rahman, et al.
Published: (2025-12-01) -
The Clinical Frailty Scale and incidence of adverse outcomes in older patients with hip fractures in Qatar
by: Shirmila Syamala, et al.
Published: (2025-07-01)